Dorota Ciołczyk-Wierzbicka

8PUBLICATIONS
2CO-AUTHORS
Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2025
Changes in Melanoma Cell Morphology Following Inhibition of Cell Invasion by Third-Generation mTOR Kinase Inhibitors.

Dorota Ciołczyk-Wierzbicka, Martyna Sikorska-Duplicka, Marta Zarzycka

|Nov 27, 2024
Treatment of Melanoma Cells with Chloroquine and Everolimus Activates the Apoptosis Process and Alters Lipid Redistribution.

Dorota Ciołczyk-Wierzbicka, Marta Zarzycka, Wojciech Placha

|May 09, 2023
Correction to: Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells.

Dorota Ciołczyk-Wierzbicka, Agnieszka Krawczyk, Marta Zarzycka

|Apr 25, 2023
Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells.

Dorota Ciołczyk-Wierzbicka, Agnieszka Krawczyk, Marta Zarzycka

|Oct 06, 2019
mTOR inhibitor everolimus reduces invasiveness of melanoma cells.

Dorota Ciołczyk-Wierzbicka, Dorota Gil, Marta Zarzycka

|Mar 09, 2019
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells.

Dorota Ciołczyk-Wierzbicka, Marta Zarzycka, Dorota Gil

Pageof 2